-
1.
-
2.
公开(公告)号:EP4056573B1
公开(公告)日:2024-11-06
申请号:EP20881417.8
申请日:2020-10-30
发明人: PARK, Bum-Joon
IPC分类号: C07D493/04 , A61K31/37 , A61P21/00 , A23L33/10
-
公开(公告)号:EP4452978A1
公开(公告)日:2024-10-30
申请号:EP22908912.3
申请日:2022-12-22
IPC分类号: C07D471/04 , A61K31/437 , A61K31/4545 , A61K31/513 , A61K47/55 , A61P1/00 , A61P11/00 , A61P19/00 , A61P21/00 , A61P25/00 , A61P29/00 , A61P31/00 , A61P35/00 , A61P37/00 , A61P43/00 , A61P9/00
-
4.
公开(公告)号:EP4407035A3
公开(公告)日:2024-10-30
申请号:EP24163078.9
申请日:2017-04-14
摘要: Described herein are recombinant AAV vectors comprising a polynucleotide sequence comprising β-sarcoglycan and methods of using the recombinant vectors to reduce or prevent fibrosis in a mammalian subject suffering from a muscular dystrophy. Also described herein are combination therapies comprising administering AAV vector(s) expressing β-sarcoglycan and miR-29c to a mammalian subject suffering from a muscular dystrophy.
-
公开(公告)号:EP3164415B1
公开(公告)日:2024-10-30
申请号:EP15734351.8
申请日:2015-07-03
-
公开(公告)号:EP4447994A1
公开(公告)日:2024-10-23
申请号:EP22906851.5
申请日:2022-12-13
-
公开(公告)号:EP4447975A1
公开(公告)日:2024-10-23
申请号:EP22836103.6
申请日:2022-12-13
-
公开(公告)号:EP4149620B1
公开(公告)日:2024-10-23
申请号:EP21730365.0
申请日:2021-05-12
发明人: KOCH, Kevin , HUNT, Kevin , SCHLACHTER, Stephen , RUSSELL, Alan
IPC分类号: A61P21/00 , C07D409/04 , C07D413/04 , C07D413/14 , C07D417/04 , A61K31/501
-
公开(公告)号:EP4445905A1
公开(公告)日:2024-10-16
申请号:EP23382344.2
申请日:2023-04-14
发明人: SÁNCHEZ ÁLVAREZ, Mikel , SÁNCHEZ ARIZMENDIARRIETA, Pello , DELGADO SAN VICENTE, Diego , BEITIA SAN VICENTE, Maider
摘要: The present invention belongs to the field of biotechnology and concerns a method of obtaining a plasma enriched in platelets and plasma molecules and the plasma obtained by this method. The method comprises the concentration of a red blood cell-free plasma with a hydroxyalkyl acrylic hydrogel.
-
公开(公告)号:EP4410378A3
公开(公告)日:2024-10-09
申请号:EP24162480.8
申请日:2017-06-30
IPC分类号: C12N9/22 , A61K38/46 , A61P1/04 , A61P1/16 , A61P3/10 , A61P7/00 , A61P9/00 , A61P15/00 , A61P17/00 , A61P21/00 , A61P25/00 , A61P27/00 , A61P29/00 , A61P31/04 , A61P37/02
CPC分类号: C12Y301/21001 , C07K2317/7220130101 , C07K2319/3020130101 , C12Y301/27005 , A61K38/00 , C12N9/22 , A61P1/00 , A61P1/04 , A61P1/16 , A61P15/00 , A61P17/00 , A61P19/02 , A61P21/00 , A61P25/00 , A61P27/02 , A61P29/00 , A61P31/04 , A61P3/10 , A61P37/02 , A61P7/00 , A61P7/06 , A61P9/00
摘要: The invention provides for optimized binuclease fusion proteins with increased pharmacokinetic properties. The optimized binuclease fusion proteins of the invention two or more nuclease domains (e.g., RNase and DNase domain) operably coupled to an Fc domain. The invention also provides methods of treating or preventing a condition associated with an abnormal immune response.
-
-
-
-
-
-
-
-
-